Physician
Hematology
Chitra Hosing, MB
|
|
Give Review
Chitra Hosing, MB works in the field of Hematology. She graduated from Baylor College of Medicine. Chitra Hosing is a published physician. She has 53 publications published. The most current publication "Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia." Chitra Hosing, MB accepts Medicare payments and is listed with Medicare.gov.
Publications
- Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index.
- Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
- Autologous hematopoietic stem Cell transplantation in light chain amyloidosis (AL) with renal involvement.
- Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
- Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
- Outcomes of Haploidentical Stem Cell Transplantation for Lymphoma with Melphalan-Based Conditioning.
- Enforced fucosylation of cord blood hematopoietic Cells accelerates neutrophil and platelet engraftment after transplantation.
- Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hemato...
- General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation.
- Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem Cell transplantation for relapsed myeloma.
- Topical cidofovir-induced Acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections.
- Concise Review: Umbilical Cord Blood Transplantation: Past, Present, and Future.
- Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome.
- Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem Cell transplant recipients with indwelling central venous catheters at a c...
- Clinical characteristics and outcomes in patients with Acute promyelocytic leukaemia and hyperleucocytosis.
- Progress in Novel Cellular Therapy Options for Chronic Lymphocytic Leukemia: The MD Anderson Perspective.
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unre...
- Short-term cardiac toxicity of autologous hematopoietic stem Cell transplant for multiple myeloma.
- Donor Cell-Derived Myelodysplastic Syndrome With Ring Chromosome 7 After Allogeneic Hematopoietic Stem Cell Transplant in 2 Patients With Lymphomas as Primary Disease.
- Is there an expiration date for a cord blood unit in storage?
- An Immunodeficiency Scoring Index to predict poor outcomes in hematopoietic Cell transplant recipients with respiratory syncytial virus infections.
- Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations.
- The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.
- Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patients.
- Low rate of infusional toxicity after expanded cord blood transplantation.
- The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant.
- Peripheral blood stem Cell yield calculated using preapheresis absolute CD34+ Cell count, peripheral blood volume processed, and donor body weight accurately predicts ...
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: ...
- Infusion of donor-derived CD19-redirected-virus-specific T Cells for B-Cell malignancies relapsed after allogeneic stem Cell transplant: a phase I study.
- Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor Cell mobilization.
- Impact of t(11;14)(q13;q32) on the Outcome of Autologous Hematopoietic Cell Transplantation in Multiple Myeloma.
- A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients w...
- Outcomes of adults with Acute lymphoblastic leukemia (ALL) following relapse post allogeneic hematopoietic stem cell transplantation (HSCT).
- Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem Cell transplant recipients with respiratory syncytial virus infections.
- Oral lenalidomide with rituximab in relapsed or refractory diffuse large Cell, follicular and transformed lymphoma: a phase II clinical trial.
- Augmentation of blood dendritic Cells by extracorporeal photopheresis in patients with leukemic cutaneous T-Cell lymphoma and graft-versus-host disease.
- High-dose chemotherapy and Autologous Stem Cell Transplantation For Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
- Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.
- Incidence and natural history of pure red Cell aplasia in major ABO-mismatched haematopoietic Cell transplantation.
- Cord-blood engraftment with ex vivo mesenchymal-Cell coculture.
- CARs in Chronic Lymphocytic Leukemia - Ready to Drive.
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome.
- High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-Cell transplantation in patients with refractory lymphoid malignancies.
- Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with Acute lymphoblastic leukemia.
- An Adaptive Randomized Trial of Intermittent Dosing Schedule of Aerosolized Ribavirin in Cancer Patients with Respiratory Syncytial Virus Infections.
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
- Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell...
- Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular Lymphoma: 12-year results.
- Hepatosplenic gamma-delta T-Cell lymphoma: clinicopathological features and treatment.
- Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem Cell transplantation for hematologic malignancies.
Schools
Lady Hardinge Medical College University Of Delhi
Westchester Co Mc
Baylor College Of Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
Baylor College of Medicine -
New York Medical College -
Lady Hardinge Medical College
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1245322262 | |
| NPPES Provider LastName | HOSING | |
| NPPES Provider FirstName | CHITRA | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 477.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1245322262 |
| Last Name Of The Provider | HOSING |
| First Name Of The Provider | CHITRA |
| View All |
Similar Doctors
|
|
Dr. Anna Belcheva, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajjai S. Alva, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Ramirez, MD |
|
|
Dr. Jeri Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cesar A. De Las Casas, MD |
|
|
Dr. Kenneth K. Wu, MD |
|
|
Dr. James Murray, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony Padula, MD |
|
|
Dr. Zehra Kapadia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milind Javle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gauri R. Varadhachary, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Marco G. De Lima, MD |
|
|
Dr. Christopher B. Benton, MD |
|
|
Dr. Guiying Hu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aaron J. Schueneman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadia Saleem, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Michael W. Thompson |